Status:
UNKNOWN
Dipeptide Alanyl Glutamine and Postoperative Insulin Resistance in Colon Carcinoma Patients
Lead Sponsor:
Medical Center Alkmaar
Conditions:
Colon Carcinoma
Eligibility:
MALE
18-75 years
Phase:
NA
Brief Summary
Rationale: It is well known that insulin resistance occurs after mediocre and intensive surgery, such as colon cancer surgery. Disturbances in insulin action negatively affect the postoperative recove...
Eligibility Criteria
Inclusion
- Age between 18 and 75 years
- Colon cancer patients scheduled for elective open abdominal surgery
- Capable of giving informed consent
Exclusion
- Patients who are participating in another clinical trial
- Unable to receive oral intake
- Major malabsorption disorder of the gut
- Patients with diabetes mellitus
- BMI above 30 kg/m2
- Use of certain medication: thyroid medication, corticosteroids, diuretic medication
- Known bleeding disorders or increased PTT and or APTT
- Any medical condition except for colon cancer
Key Trial Info
Start Date :
December 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2013
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00922688
Start Date
December 1 2010
End Date
May 1 2013
Last Update
July 21 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical Center Alkmaar
Alkmaar, North Holland, Netherlands, 1815 JD